MedStartr

www.medstartr.vc

VCMatch tracks MedStartr as an investor focused on Healthtech, Digital Health, and Biotech companies, Pre-Seed and Seed rounds, United States, New York, and Global markets, and $100k to $1m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$100k to $1m

Stages

Pre-Seed, Seed

Focus Areas

Healthtech, Digital Health, Biotech

Geography

United States, New York, and Global

Investment Thesis

MedStartr Venture Fund believes that crowd validation is a superior method for identifying and selecting healthcare startups. They have developed a data-driven investment approach that converts startup selection ‘from a black art to a science’ by leveraging their unique position at the intersection of healthcare innovation communities. Their core belief is that when patients, doctors, institutional leaders, and investors collectively validate a company through contests and challenges, that company is over 20 times more likely to be successful.

Is MedStartr right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

MedStartr is most relevant for founders raising Pre-Seed and Seed rounds in Healthtech, Digital Health, Biotech, and Medtech, especially across United States, New York, and Global, with public check-size signals around $100k to $1m.

Focus statement

MedStartr invests in early-stage healthcare startups ($100k-$1M) that have been validated through their proprietary crowd-based platform and challenge model. They focus exclusively on healthcare innovations sourced from their extensive community network and sponsorship-driven contests.

Value Add

Proprietary crowd-validation methodology - companies backed by their healthcare crowd are 20x more likely to succeed
Massive deal sourcing capability - attract over 1,000 pre-revenue companies annually
Unique ecosystem combining AI metrics with crowd intelligence for company selection
3-year MedStartr Acceleration Program (MAP) providing up to $250k in in-kind support beyond capital
Deep healthcare domain expertise - team with 75+ years combined healthcare experience and 100+ years combined team experience
Access to physician leaders, KOLs, healthcare systems, payers, and policy-makers for portfolio company pilots and clinical studies
Industry-leading performance over first two funds with demonstrated track record of exits
Holdings in complementary platforms (MedStartr Crowd, CrowdEquity offering, MedStartr Labs)